MedTech Cirdan has raised £2.3 million to expand its operations and create up to 25 new jobs.

The digital pathology firm has clients in over 150 laboratories and hospitals across 20 countries and six continents.

The Cirdan platform, which includes specimen imaging solutions, patient and clinician apps as well as the Laboratory information system, collects critical information in a lean and expeditious way, to help transform the time taken for diagnosis and provide new insights into healthcare data. 

It claims to improve efficiency and agility, provide greater control and visibility, and seamlessly integrate with digital pathology and AI.

The Lisburn company is growing its revenues with expected 80%+ year on year growth in 2024.

‘Ground-breaking’ global consensus on oxygen use in wound care

The investment was led by Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund (NI). Other investors include Clarendon Fund Managers and high net worth private investors.

“I would like to take this opportunity to thank our investors for their continued support. This in addition to securing several new contracts will be used to accelerate our operational expansion and deliver on our strong order book for 2023 and beyond,” said Stephen Dunniece, director at Cirdan.

Denise Sidhu, partner at Kernel Capital, added: “Cirdan is a company on a positive growth trajectory with an excellent product, strong team and ‘blue-chip’ clients across six continents.

“The company is ideally placed to capitalise on the accelerated shift from traditional patient care to digital pathology which has the potential to revolutionise timely disease diagnosis leading to better and faster patient care.”

Former Benevolent AI talent to power UK launch of quantum startup